ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Closed-loop Automated Insulin Delivery (AID) System Market Research Report 2026
Published Date: 2026-04-16
|
Report Code: QYRE-Auto-31Q16705
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Closed loop Automated Insulin Delivery AID System Market Research Report 2024
BUY CHAPTERS

Global Closed-loop Automated Insulin Delivery (AID) System Market Research Report 2026

Code: QYRE-Auto-31Q16705
Report
2026-04-16
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd
Medtrum

Closed-loop Automated Insulin Delivery (AID) System Market

The global Closed-loop Automated Insulin Delivery (AID) System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Closed-loop Automated Insulin Delivery (AID) System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
The North American market for Closed-loop Automated Insulin Delivery (AID) System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Closed-loop Automated Insulin Delivery (AID) System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Closed-loop Automated Insulin Delivery (AID) System include Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Closed-loop Automated Insulin Delivery (AID) System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Closed-loop Automated Insulin Delivery (AID) System. The Closed-loop Automated Insulin Delivery (AID) System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Closed-loop Automated Insulin Delivery (AID) System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Closed-loop Automated Insulin Delivery (AID) System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Closed-loop Automated Insulin Delivery (AID) System Market Report

Report Metric Details
Report Name Closed-loop Automated Insulin Delivery (AID) System Market
Segment by Type
  • Hybrid Closed Loop Systems
  • DIY Closed Loop Systems
by Application
  • Children with Type 1 Diabetes
  • Adults with Type 1 Diabetes
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Closed-loop Automated Insulin Delivery (AID) System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Closed-loop Automated Insulin Delivery (AID) System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Closed-loop Automated Insulin Delivery (AID) System Market report?

Ans: The main players in the Closed-loop Automated Insulin Delivery (AID) System Market are Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum

What are the Application segmentation covered in the Closed-loop Automated Insulin Delivery (AID) System Market report?

Ans: The Applications covered in the Closed-loop Automated Insulin Delivery (AID) System Market report are Children with Type 1 Diabetes, Adults with Type 1 Diabetes

What are the Type segmentation covered in the Closed-loop Automated Insulin Delivery (AID) System Market report?

Ans: The Types covered in the Closed-loop Automated Insulin Delivery (AID) System Market report are Hybrid Closed Loop Systems, DIY Closed Loop Systems

1 Closed-loop Automated Insulin Delivery (AID) System Market Overview
1.1 Product Definition
1.2 Closed-loop Automated Insulin Delivery (AID) System by Type
1.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Value by Type: 2025 vs 2032
1.2.2 Hybrid Closed Loop Systems
1.2.3 DIY Closed Loop Systems
1.3 Closed-loop Automated Insulin Delivery (AID) System by Application
1.3.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Value by Application: 2025 vs 2032
1.3.2 Children with Type 1 Diabetes
1.3.3 Adults with Type 1 Diabetes
1.4 Global Closed-loop Automated Insulin Delivery (AID) System Market Size Estimates and Forecasts
1.4.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue 2021–2032
1.4.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales 2021–2032
1.4.3 Global Closed-loop Automated Insulin Delivery (AID) System Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Closed-loop Automated Insulin Delivery (AID) System Market Competition by Manufacturers
2.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Manufacturers (2021–2026)
2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Closed-loop Automated Insulin Delivery (AID) System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Product Types and Applications
2.7 Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Date of Entry into the Industry
2.8 Global Closed-loop Automated Insulin Delivery (AID) System Market Competitive Situation and Trends
2.8.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Closed-loop Automated Insulin Delivery (AID) System Players Market Share by Revenue
2.8.3 Global Closed-loop Automated Insulin Delivery (AID) System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Closed-loop Automated Insulin Delivery (AID) System Market Scenario by Region
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region: 2021–2032
3.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region: 2021–2026
3.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region: 2027–2032
3.3 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region: 2021–2032
3.3.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region: 2021–2026
3.3.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region: 2027–2032
3.4 North America Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Country
3.4.1 North America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2021–2032)
3.4.3 North America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Country
3.5.1 Europe Closed-loop Automated Insulin Delivery (AID) System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2021–2032)
3.5.3 Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Region
3.6.1 Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2021–2032)
3.6.3 Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Country
3.7.1 Latin America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2021–2032)
3.7.3 Latin America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Country
3.8.1 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2021–2032)
3.8.3 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2021–2032)
4.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2021–2026)
4.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2027–2032)
4.1.3 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2021–2032)
4.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2021–2032)
4.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2021–2026)
4.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2027–2032)
4.2.3 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2021–2032)
4.3 Global Closed-loop Automated Insulin Delivery (AID) System Price by Type (2021–2032)
5 Segment by Application
5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2021–2032)
5.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2021–2026)
5.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2027–2032)
5.1.3 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2021–2032)
5.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2021–2032)
5.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2021–2026)
5.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2027–2032)
5.2.3 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2021–2032)
5.3 Global Closed-loop Automated Insulin Delivery (AID) System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Tandem Diabetes Care
6.2.1 Tandem Diabetes Care Company Information
6.2.2 Tandem Diabetes Care Description and Business Overview
6.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.2.5 Tandem Diabetes Care Recent Developments/Updates
6.3 Admetsys
6.3.1 Admetsys Company Information
6.3.2 Admetsys Description and Business Overview
6.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.3.5 Admetsys Recent Developments/Updates
6.4 Insulet
6.4.1 Insulet Company Information
6.4.2 Insulet Description and Business Overview
6.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Insulet Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.4.5 Insulet Recent Developments/Updates
6.5 Defymed
6.5.1 Defymed Company Information
6.5.2 Defymed Description and Business Overview
6.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Defymed Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.5.5 Defymed Recent Developments/Updates
6.6 Beta Bionics (iLet)
6.6.1 Beta Bionics (iLet) Company Information
6.6.2 Beta Bionics (iLet) Description and Business Overview
6.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.6.5 Beta Bionics (iLet) Recent Developments/Updates
6.7 Bigfoot Biomedical
6.7.1 Bigfoot Biomedical Company Information
6.7.2 Bigfoot Biomedical Description and Business Overview
6.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.7.5 Bigfoot Biomedical Recent Developments/Updates
6.8 Dexcom
6.8.1 Dexcom Company Information
6.8.2 Dexcom Description and Business Overview
6.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.8.5 Dexcom Recent Developments/Updates
6.9 MicroTech Medical (Hangzhou) Co., Ltd.
6.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Company Information
6.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Description and Business Overview
6.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
6.10 Medtrum
6.10.1 Medtrum Company Information
6.10.2 Medtrum Description and Business Overview
6.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.10.5 Medtrum Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Closed-loop Automated Insulin Delivery (AID) System Industry Chain Analysis
7.2 Closed-loop Automated Insulin Delivery (AID) System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Closed-loop Automated Insulin Delivery (AID) System Production Mode & Process Analysis
7.4 Closed-loop Automated Insulin Delivery (AID) System Sales and Marketing
7.4.1 Closed-loop Automated Insulin Delivery (AID) System Sales Channels
7.4.2 Closed-loop Automated Insulin Delivery (AID) System Distributors
7.5 Closed-loop Automated Insulin Delivery (AID) System Customer Analysis
8 Closed-loop Automated Insulin Delivery (AID) System Market Dynamics
8.1 Closed-loop Automated Insulin Delivery (AID) System Industry Trends
8.2 Closed-loop Automated Insulin Delivery (AID) System Market Drivers
8.3 Closed-loop Automated Insulin Delivery (AID) System Market Challenges
8.4 Closed-loop Automated Insulin Delivery (AID) System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Medtronic Inc
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd
Medtrum
List of Tables
 Table 1. Global Closed-loop Automated Insulin Delivery (AID) System Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Closed-loop Automated Insulin Delivery (AID) System Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Closed-loop Automated Insulin Delivery (AID) System Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Closed-loop Automated Insulin Delivery (AID) System Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Closed-loop Automated Insulin Delivery (AID) System Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Closed-loop Automated Insulin Delivery (AID) System Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Closed-loop Automated Insulin Delivery (AID) System, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Product Types and Applications
 Table 12. Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Closed-loop Automated Insulin Delivery (AID) System Companies by Tier (Tier 1, Tier 2, Tier 3), based on Closed-loop Automated Insulin Delivery (AID) System Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region (K Units), 2021–2026
 Table 18. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Region (2021–2026)
 Table 19. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region (K Units), 2027–2032
 Table 20. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Region (2027–2032)
 Table 21. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Region (2021–2026)
 Table 23. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Region (2027–2032)
 Table 25. North America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Closed-loop Automated Insulin Delivery (AID) System Sales by Country (K Units), 2021–2026
 Table 27. North America Closed-loop Automated Insulin Delivery (AID) System Sales by Country (K Units), 2027–2032
 Table 28. North America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (K Units), 2021–2026
 Table 32. Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (K Units), 2027–2032
 Table 33. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Closed-loop Automated Insulin Delivery (AID) System Sales by Country (K Units), 2021–2026
 Table 42. Latin America Closed-loop Automated Insulin Delivery (AID) System Sales by Country (K Units), 2027–2032
 Table 43. Latin America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Closed-loop Automated Insulin Delivery (AID) System Sales (K Units) by Type (2021–2026)
 Table 51. Global Closed-loop Automated Insulin Delivery (AID) System Sales (K Units) by Type (2027–2032)
 Table 52. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2021–2026)
 Table 53. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2027–2032)
 Table 54. Global Closed-loop Automated Insulin Delivery (AID) System Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Closed-loop Automated Insulin Delivery (AID) System Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2021–2026)
 Table 57. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2027–2032)
 Table 58. Global Closed-loop Automated Insulin Delivery (AID) System Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Closed-loop Automated Insulin Delivery (AID) System Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Closed-loop Automated Insulin Delivery (AID) System Sales (K Units) by Application (2021–2026)
 Table 61. Global Closed-loop Automated Insulin Delivery (AID) System Sales (K Units) by Application (2027–2032)
 Table 62. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2021–2026)
 Table 63. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2027–2032)
 Table 64. Global Closed-loop Automated Insulin Delivery (AID) System Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Closed-loop Automated Insulin Delivery (AID) System Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2021–2026)
 Table 67. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2027–2032)
 Table 68. Global Closed-loop Automated Insulin Delivery (AID) System Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Closed-loop Automated Insulin Delivery (AID) System Price (US$/Unit) by Application (2027–2032)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Medtronic Closed-loop Automated Insulin Delivery (AID) System Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Tandem Diabetes Care Company Information
 Table 76. Tandem Diabetes Care Description and Business Overview
 Table 77. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product
 Table 79. Tandem Diabetes Care Recent Developments/Updates
 Table 80. Admetsys Company Information
 Table 81. Admetsys Description and Business Overview
 Table 82. Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Admetsys Closed-loop Automated Insulin Delivery (AID) System Product
 Table 84. Admetsys Recent Developments/Updates
 Table 85. Insulet Company Information
 Table 86. Insulet Description and Business Overview
 Table 87. Insulet Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Insulet Closed-loop Automated Insulin Delivery (AID) System Product
 Table 89. Insulet Recent Developments/Updates
 Table 90. Defymed Company Information
 Table 91. Defymed Description and Business Overview
 Table 92. Defymed Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Defymed Closed-loop Automated Insulin Delivery (AID) System Product
 Table 94. Defymed Recent Developments/Updates
 Table 95. Beta Bionics (iLet) Company Information
 Table 96. Beta Bionics (iLet) Description and Business Overview
 Table 97. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product
 Table 99. Beta Bionics (iLet) Recent Developments/Updates
 Table 100. Bigfoot Biomedical Company Information
 Table 101. Bigfoot Biomedical Description and Business Overview
 Table 102. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product
 Table 104. Bigfoot Biomedical Recent Developments/Updates
 Table 105. Dexcom Company Information
 Table 106. Dexcom Description and Business Overview
 Table 107. Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Dexcom Closed-loop Automated Insulin Delivery (AID) System Product
 Table 109. Dexcom Recent Developments/Updates
 Table 110. MicroTech Medical (Hangzhou) Co., Ltd. Company Information
 Table 111. MicroTech Medical (Hangzhou) Co., Ltd. Description and Business Overview
 Table 112. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product
 Table 114. MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
 Table 115. Medtrum Company Information
 Table 116. Medtrum Description and Business Overview
 Table 117. Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Medtrum Closed-loop Automated Insulin Delivery (AID) System Product
 Table 119. Medtrum Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Closed-loop Automated Insulin Delivery (AID) System Distributors List
 Table 123. Closed-loop Automated Insulin Delivery (AID) System Customers List
 Table 124. Closed-loop Automated Insulin Delivery (AID) System Market Trends
 Table 125. Closed-loop Automated Insulin Delivery (AID) System Market Drivers
 Table 126. Closed-loop Automated Insulin Delivery (AID) System Market Challenges
 Table 127. Closed-loop Automated Insulin Delivery (AID) System Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Closed-loop Automated Insulin Delivery (AID) System
 Figure 2. Global Closed-loop Automated Insulin Delivery (AID) System Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Closed-loop Automated Insulin Delivery (AID) System Market Share by Type: 2025 & 2032
 Figure 4. Hybrid Closed Loop Systems Product Picture
 Figure 5. DIY Closed Loop Systems Product Picture
 Figure 6. Global Closed-loop Automated Insulin Delivery (AID) System Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Closed-loop Automated Insulin Delivery (AID) System Market Share by Application: 2025 & 2032
 Figure 8. Children with Type 1 Diabetes
 Figure 9. Adults with Type 1 Diabetes
 Figure 10. Global Closed-loop Automated Insulin Delivery (AID) System Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Closed-loop Automated Insulin Delivery (AID) System Market Size (US$ Million), 2021–2032
 Figure 12. Global Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), 2021–2032
 Figure 13. Global Closed-loop Automated Insulin Delivery (AID) System Average Price (US$/Unit), 2021–2032
 Figure 14. Closed-loop Automated Insulin Delivery (AID) System Report Years Considered
 Figure 15. Closed-loop Automated Insulin Delivery (AID) System Sales Share by Manufacturers in 2025
 Figure 16. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Closed-loop Automated Insulin Delivery (AID) System Players: Market Share by Revenue in Closed-loop Automated Insulin Delivery (AID) System in 2025
 Figure 18. Closed-loop Automated Insulin Delivery (AID) System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country (2021–2032)
 Figure 21. North America Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2021–2032)
 Figure 22. United States Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country (2021–2032)
 Figure 25. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Region (2021–2032)
 Figure 33. China Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Closed-loop Automated Insulin Delivery (AID) System by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Closed-loop Automated Insulin Delivery (AID) System by Type (2021–2032)
 Figure 53. Global Closed-loop Automated Insulin Delivery (AID) System Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Closed-loop Automated Insulin Delivery (AID) System by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Closed-loop Automated Insulin Delivery (AID) System by Application (2021–2032)
 Figure 56. Global Closed-loop Automated Insulin Delivery (AID) System Price (US$/Unit) by Application (2021–2032)
 Figure 57. Closed-loop Automated Insulin Delivery (AID) System Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Automatic Insulin Delivery Systems Market Insights Forecast to 2030
Global Artificial Pancreas Closed Loop System Market Research Report 2024
Global Smart Insulin Infusion Pumps Market Research Report 2024
Global Closed Loop Artificial Pancreas System Market Research Report 2024
Global Automated Insulin Delivery Device Market Research Report 2024
Global Hybrid Closed loop Insulin Delivery System Market Research Report 2024
Global Automated Insulin Delivery Systems Market Research Report 2024
Global Diabetes Treatment Medical Devices Market Research Report 2024
Global Human Insulin Delivery System Market Insights Forecast to 2030
Global Insulin Pump Market Research Report 2025
Global Diabetes Insulin Pumps Market Research Report 2024
Artificially Intelligent Insulin Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Management System Market Insights Forecast to 2030
Global Insulin Injection Equipment Market Research Report 2025
Automatic Insulin Dosing Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Pump and Supplies Market Research Report 2024
Global Wearable Insulin Pump Market Research Report 2025
Global Insulin Pumps and Accessories Market Research Report 2024
Global Tube Insulin Pumps Market Research Report 2024
Smart Insulin Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions